How is MediXall Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
26.7%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MediXall Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
Take a look at our analysis of MDXL’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access MediXall Group's filings and announcements here.
What is MediXall Group's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: Unable to evaluate MDXL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate MDXL's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MDXL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MDXL's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MDXL's dividend in 3 years as they are not forecast to pay a notable one for the US market.
What is the CEO of MediXall Group's salary, the management and board of directors tenure and is there insider trading?
2.0yrs
Average management tenure
CEO
NeilSwartz(57yo)
3yrs
Tenure
US$150,000
Compensation
Mr. Neil Swartz, CPA, serves as the Interim Chief Executive Officer at MediXall Group, Inc since 2016 and served as its President. Mr. Swartz has been the Interim Chief Executive Officer and Interim Presid ...
Management Age and Tenure
2.0yrs
Average Tenure
57yo
Average Age
Experienced Management: MDXL's management team is considered experienced (2 years average tenure).
Board Age and Tenure
1.8yrs
Average Tenure
60yo
Average Age
Experienced Board: MDXL's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.1%.
Management Team
Tim Hart (60yo)
CFO, Treasurer
Tenure: 7yrs
Compensation: US$250.00k
Neil Swartz (57yo)
Interim Chief Executive Officer
Tenure: 3yrs
Compensation: US$150.00k
Michael Swartz (28yo)
President of Medixall.com
Tenure: 0.7yrs
Guy Connor (57yo)
Executive Vice President
Tenure: 0yrs
John Howard
Senior Vice President of Laboratory Services
Tenure: 1yrs
Board Members
Noel Guillama-Alvarez (60yo)
Chairman of the Board
Tenure: 3yrs
Tim Hart (60yo)
CFO, Treasurer
Tenure: 7yrs
Compensation: US$250.00k
Howard Braverman (72yo)
Member of Strategic Advisory Board
Tenure: 0.8yrs
Steven Gass
Member of Strategic Advisory Board
Tenure: 1.3yrs
Winston Marshall (54yo)
Member of Medical Advisory Board
Tenure: 1.8yrs
John DeLuca
Member of Medical Advisory Board
Tenure: 1.8yrs
Kenneth Janson
Member of Medical Advisory Board
Tenure: 1.8yrs
Benjamin Frosch
Member of Strategic Advisory Board
Tenure: 1.3yrs
Ellis Ellis
Member of Advisory Board
Tenure: 0.8yrs
Company Information
MediXall Group, Inc.'s company bio, employee growth, exchange listings and data sources
MediXall Group, Inc., together with its subsidiaries, operates healthcare marketplace platform in the United States. The company’s cloud- based MediXall.com platform that connects patients with healthcare ...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2019/12/14 01:26
End of Day Share Price
2019/12/11 00:00
Earnings
2019/09/30
Annual Earnings
2018/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.